Peripheral Arterial Diseases
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genetic Variants in the Bone Morphogenic Protein Gene Family Modify the Association between Residential Exposure to Traffic and Peripheral Arterial Disease.
|
27082954 |
2016 |
Malignant neoplasm of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
In this study, we used quantitative proteomic analyses to compare a highly metastatic cancer cell line and a parental breast cancer cell line; and observed that NDUFB9, an accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (complex I), was down-regulated in highly metastatic breast cancer cells.
|
26641458 |
2015 |
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In this study, we used quantitative proteomic analyses to compare a highly metastatic cancer cell line and a parental breast cancer cell line; and observed that NDUFB9, an accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (complex I), was down-regulated in highly metastatic breast cancer cells.
|
26641458 |
2015 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, we demonstrated that loss of NDUFB9 promotes MDA-MB-231 cells proliferation, migration, and invasion because of elevated levels of mtROS, disturbance of the NAD+/NADH balance, and depletion of mtDNA.
|
26641458 |
2015 |
Histiocytoid Cardiomyopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, NDUFAF2 and NDUFB9, confirming that Histiocytoid CM is genetically heterogeneous.
|
25921236 |
2015 |
MITOCHONDRIAL COMPLEX I DEFICIENCY
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9.
|
22200994 |
2012 |
MITOCHONDRIAL COMPLEX I DEFICIENCY
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9.
|
22200994 |
2012 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24
|
0.500 |
GeneticVariation
|
disease |
UNIPROT |
Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9.
|
22200994 |
2012 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9.
|
22200994 |
2012 |
Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9.
|
22200994 |
2012 |
Weight Gain
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice.
|
19030233 |
2008 |
Branchio-Oto-Renal Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To identify whether mutations in NDUFB9 are involved in causing the BOR syndrome, we screened 9 BOR families which did not show mutations in the EYA1 gene by heteroduplex analysis; however, no mutations were found.
|
10077726 |
1999 |
Acidosis, Lactic
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypertrophic Cardiomyopathy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fetal Distress
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fetal Growth Retardation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hepatomegaly
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypoglycemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Lethargy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Leukodystrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|